GlassScriptPhysician profile
Jyotsna Sahni
NPI 1417160599
$37,512.98
in general payments reported to CMS, 2019-2025
27 companies · $4,863 in 2025
The $4,863 reported for 2025 was more than what 93% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $736 · 2020: $1,324 · 2021: $1,681 · 2022: $1,356 · 2023: $11K · 2024: $16K · 2025: $4,863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Food and Beverage: $9,894 · Travel and Lodging: $2,934 · Consulting Fee: $1,625 · Education: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,658.00 |
| Food and Beverage | $9,894.24 |
| Travel and Lodging | $2,933.70 |
| Consulting Fee | $1,625.00 |
| Education | $304.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $23,605.33 | 2019-2025 | |
| Inspire Medical Systems, INC. | $4,044.34 | 2019-2025 | Inspire |
| Zoll Respicardia, INC. | $2,317.18 | 2020-2025 | Remede System |
| Idorsia Pharmaceuticals US INC | $1,998.84 | 2022-2025 | Quviviq, Quviviq |
| Harmony Biosciences LLC | $1,462.74 | 2020-2025 | Wakix |
| Avadel Cns Pharmaceuticals, LLC | $726.71 | 2023-2025 | Lumryz |
| Ucb, INC. | $582.83 | 2019-2021 | |
| Eisai INC. | $379.45 | 2020-2022 | |
| Itamar Medical INC | $364.38 | 2021-2024 | Watchpatone |
| Axsome Therapeutics, INC. | $331.07 | 2024-2025 | Sunosi, Auvelity |
| Teva Pharmaceuticals USA, INC. | $220.03 | 2019 | |
| Vanda Pharmaceuticals INC. | $205.27 | 2020-2023 | Hetlioz |
| Silk Road Medical, INC. | $169.62 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Medtronic, INC. | $159.17 | 2023 | Na |
| Arbor Pharmaceuticals, INC. | $151.04 | 2020-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $146.52 | 2024 | Carto 3 |
| Lilly USA, LLC | $138.54 | 2025 | Kisunla, Zepbound |
| Merck Sharp & Dohme LLC | $129.83 | 2020-2023 | Belsomra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $111.44 | 2023 | Lifevest |
| Boston Scientific Corporation | $95.42 | 2023 | Watchman Flx |
| Philips North America LLC | $66.69 | 2023-2025 | (6299) Dreamwear, Dreamwear |
| Noctrix Health, INC. | $25.52 | 2025 | Nidra |
| Almatica Pharma LLC | $17.76 | 2023 | Loreev Xr |
| Fisher & Paykel Healthcare INC | $17.71 | 2023 | Fisher & Paykel Healthcare |
| Aerin Medical INC. | $16.11 | 2023 | |
| Azurity Pharmaceuticals, INC. | $15.14 | 2023 | Horizant |
| Aytu Biopharma, INC. | $14.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jyotsna Sahni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.